Neuromyelitis Optica Spectrum Disorder Attack: Clinical Trials

1 trial for Neuromyelitis Optica Spectrum Disorder Attack, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Neuromyelitis Optica Spectrum Disorder Attack: new trials by email Literature Review of Neuromyelitis Optica Spectrum Disorder Attack trials Research Report on Neuromyelitis Optica Spectrum Disorder Attack

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study
Eculizumab+IVMP, IVIG+IVMP, IVMP - Neuromyelitis Optica Spectrum Disorder Attack
Phase 4RecruitingChinese PLA General Hospital2002026-02-012026-03-12

Narrower conditions

Neuromyelitis Optica (1)

Broader conditions

Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Cranial Nerve Diseases (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Demyelinating Diseases (1)  ·  Eye Diseases (1)  ·  Immune System Diseases (1)  ·  Myelitis, Transverse (1)  ·  Nervous System Diseases (1)  ·  Optic Nerve Diseases (1)  ·  Optic Neuritis (1)

Sponsors

Chinese PLA General Hospital (1)

Countries

China (1)